Watson Pharmaceuticals (WPI) sells its Rugby OTC pharmaceutical products and trademarks to The...
Watson Pharmaceuticals (WPI) sells its Rugby OTC pharmaceutical products and trademarks to The Harvard Drug Group for approximately $117M. The Rugy OTC portfolio includes more than 250 cough and cold, allergy, pain relief, nausea relief, nicotine gum, vitamin and nutritional supplement products sold through various healthcare outlets across the United States. The FDA had pre-cleared the deal back on October 19.
From other sites
Video at CNBC.com (Mon, 11:40AM)
at CNBC.com (Feb 18, 2015)
at CNBC.com (Feb 10, 2015)
at CNBC.com (Feb 5, 2015)
at CNBC.com (Jan 30, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs